Chiron Real Estate Inc. Common Stock (XRN)

FairStock Score: 48/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for a business I can understand and a price that protects me. Chiron is a small healthcare REIT, and the filed numbers give me pause. In fiscal year 2025, ended 2025-12-31, revenue was $526,000 but net income was a loss of $6.9M, or diluted EPS -$0.91. A year earlier, fiscal 2024, revenue was $370,000 and net income was $6.7M, or EPS $0.06. In fiscal 2023, revenue was $115,000 and net income was $21.7M, or EPS $1.13. So the top line is rising from a tiny base, but profits have collapsed; FairStock's computed Profit Growth is -51.56% and it labels this a TURNAROUND because the latest year had a loss after earlier profits. The latest filed quarter, fiscal Q2 2026 ended 2026-06-30, showed revenue of $846,000 and net income of $72.3M, but that net figure against tiny revenue suggests non-operating gains rather than durable operating strength. For a REIT, FFO/AFFO are the right measures, and they are not in the data, so I lean on dividend yield, leverage, revenue trend, and price-to-book. I do not use the Graham Number or margin of safety here because depreciation distorts REIT EPS. At the 2026-10-13 close of $32.67, FairStock calculates P/B of 1.15, a P/E of 8.78, and a 5.35% dividend yield. But debt-to-equity is 0.95, ROCE is only 1.76%, trailing free cash flow is -$187.6M, and the FCF yield is -19.5%. Altman Z-Score is 0.57, a distress signal, and Piotroski is 5/9. A 1.15 P/B and 5.35% yield are not enough if cash keeps going out and the dividend is uncovered. I see no clear moat at this scale. I would wait for FFO/AFFO and positive free cash flow before calling it a bargain.

In plain English: Chiron Real Estate Inc. owns healthcare-related real estate. The latest full-year filing shows a loss and cash is going out, so the business looks weak right now. At $32.67, the shares trade close to the value of the company's net assets and pay a 5.35% dividend, so the price looks fair rather than clearly cheap or expensive.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer